Legal Representation
Attorney
Patrick J. Jennings
USPTO Deadlines
Next Deadline
52 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
September 03, 2025
Extension Available
Until September 03, 2025
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 25, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 25, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Feb 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 3, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 19, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 30, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 31, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 12, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of benign prostatic hyperplasia and prostate cancer
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO